Hyaluronic Acid Injections for Thumb CMC Joint Osteoarthritis
Yes, hyaluronic acid injections are available and may be useful for treating thumb carpometacarpal (CMC) joint osteoarthritis, though the evidence supporting their use is limited and they are not universally recommended by all guidelines. 1
Evidence Quality and Guideline Recommendations
The EULAR (European League Against Rheumatism) guidelines from 2007 state that intra-articular hyaluronan may be useful in treating trapeziometacarpal (thumb CMC) OA with a Level IIb evidence rating, based on one uncontrolled trial showing 46% pain reduction at rest and 27% on movement after 5 months, plus one RCT suggesting hyaluronan was as effective as corticosteroid with potentially more prolonged benefit. 1
However, the 2019 EULAR update significantly changed this recommendation, stating that there is currently no evidence for clinical efficacy of hyaluronic acid preparations in hand OA and these substances should not be advocated. 2 This represents a notable reversal from the earlier guideline.
The 2020 American College of Rheumatology/Arthritis Foundation guideline does not address hyaluronic acid injections for hand/thumb OA at all, as this treatment has not been evaluated in hand OA according to their review. 3 Their recommendations against hyaluronic acid were specific to knee and hip OA only.
Clinical Research Evidence
Despite the guideline uncertainty, recent clinical trials demonstrate efficacy:
A 2020 randomized controlled trial found hyaluronic acid superior to both PRP and corticosteroids at 12 weeks, with sustained improvements in pain (VAS), function (AUSCAN score), and grip/pinch strength, while the other treatments showed deterioration after initial improvement. 4
A 2015 RCT showed hyaluronic acid was more effective than betamethasone over time, particularly in patients with more severe symptoms (baseline pain ≥5), with significantly better functionality scores at 180 days. 5
A 2023 network meta-analysis of 446 patients found no injection type superior to placebo at short-term follow-up, though PRP showed promise at medium-term (but with limited evidence quality). 6
Practical Clinical Application
When to consider hyaluronic acid injections:
- Patients with symptomatic thumb CMC OA who have inadequate response to conservative measures (splinting, NSAIDs, activity modification) 1
- Patients seeking alternatives to corticosteroids or when corticosteroids have failed 5
- Patients with more severe baseline symptoms (pain VAS ≥5, functional impairment) appear to benefit most 5
Administration protocol based on available evidence:
- Ultrasound-guided injection is recommended for accurate intra-articular placement 7, 8
- Typical dosing: 0.5-1.0 mL sodium hyaluronate per injection 7, 8
- Three injections at 7-day intervals is the most studied protocol 5
- Single injections have also shown efficacy in some studies 8
Expected outcomes:
- Pain relief may be more gradual than corticosteroids (onset over weeks rather than days) 7
- Benefits can last up to 6 months 4, 5
- Functional improvement in addition to pain relief 8, 5
- Mild local side effects (pain, swelling) lasting <3 hours occur rarely 8
Important Caveats
The evidence base has significant limitations:
- Most studies are small with short follow-up periods 1
- The 2019 EULAR guidelines explicitly state no current evidence supports efficacy 2
- Heterogeneity exists in hyaluronic acid preparations, molecular weights, and injection protocols across studies 1
- More recent high-quality evidence is needed, as acknowledged by EULAR's research agenda calling for better evaluation of hyaluronic acid benefits in thumb base OA 1
In clinical practice, hyaluronic acid injections for thumb CMC OA represent a reasonable option when other conservative treatments have failed, particularly given their favorable safety profile and potential for sustained benefit beyond corticosteroids, though patients should understand the evidence is not definitive and some major guidelines no longer support their use. 2, 4, 5